Tirzepatide represents a groundbreaking treatment agent for individuals facing type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://shaunavowp865211.blogunteer.com/39319872/tirzepatide-a-new-frontier-in-diabetes-treatment